CTLA4 and neoplasm: Indeed, the 1E6 model, which had the highest frequency of T cells and PD-L1+ myeloid cells, was the only model among the four that responded to anti-PD-L1 and anti-CTLA-4 as monotherapy after 14 days of treatment as seen by delayed tumor progression (Fig. 6, Supl.